Congestive heart failure

This phase 3 trial is testing an experimental mRNA vaccine called mRNA-1345 to see if it can protect against respiratory syncytial virus (RSV) in adults who are at high risk of severe illness. The study includes two groups: adults aged 18 to 59 with chronic health conditions like…

This completed study looked at 60 adults with acute decompensated heart failure and kidney impairment. Researchers compared three intravenous heart medications—levosimendan, dobutamine, and milrinone—to see which one improved heart and kidney function best. The goal was to find t…

This trial tests whether adding dapagliflozin—a drug commonly used for diabetes—to standard diuretic treatment helps adults hospitalized with acute heart failure. The goal is to see if it reduces fluid buildup in the lungs (measured by ultrasound), shortens hospital stays, and im…

This trial explores how intensifying neurohormonal blockade—by adding or increasing eplerenone or finerenone—affects sodium excretion in people with chronic heart failure. Researchers will measure urinary sodium before and after diuretic use across three visits to see if treatmen…

This trial tests whether a structured exercise program—combining aerobic and strength training—can improve self-care ability in people hospitalized for heart failure. Participants will be randomly assigned to either this combined program or a standard aerobic-only exercise progra…

This trial tests whether sacubitril/valsartan, a newer heart failure medication, is safer and more effective for the kidneys than ramipril, an older ACE inhibitor, in people hospitalized with acute decompensated heart failure who also have chronic kidney disease. About 515 partic…

This study tests a new device called the Doraya Catheter for people hospitalized with acute heart failure who still have too much fluid in their body even after taking water pills (diuretics). The catheter is designed to help remove the excess fluid. The study includes 30 adults …

This study observes Korean adults with chronic heart failure (NYHA class II-IV) who are starting Jardiance (empagliflozin) for the first time. The main goal is to track the drug's safety in everyday clinical practice, including any side effects or serious reactions. Researchers w…

This early-stage trial is testing a new gene therapy called AB-1002 in people with advanced heart failure (NYHA Class III). The therapy is given as a single infusion directly into the heart's blood vessels, aiming to deliver a gene that may help heart muscle pump more effectively…

This trial examines how two standard heart failure medications—bisoprolol (a beta blocker) and SGLT2 inhibitors (dapagliflozin or empagliflozin)—are processed by the body during an acute decompensated heart failure episode. Researchers will measure drug levels and heart function …

This study looks at whether vericiguat, a drug that stimulates a key enzyme, can improve exercise ability and heart pressure during activity in people with chronic heart failure and reduced ejection fraction. Participants take vericiguat alongside their usual heart medications an…

This study tested a new medicine called AZD5462 in 375 adults with stable chronic heart failure. The goal was to see if the drug could improve how well the heart pumps blood. Participants continued their usual heart failure medications while receiving either AZD5462 or a placebo.…

This study tests whether a case manager—who provides phone support, a home visit, and lifestyle counseling—can help women attend cardiac rehabilitation after a heart attack or heart surgery. Cardiac rehab is proven to reduce mortality and improve quality of life, but women are le…

This study tested a bedside device called the Reprieve Decongestion Management System in 100 hospitalized patients with acute decompensated heart failure. The device automatically adjusts the dose of a diuretic (furosemide) and saline based on the patient's real-time urine output…

This study tested a new drug called R2R01 in 33 people with worsening heart failure. Participants received either R2R01 or a placebo alongside their usual treatments. The goal was to see if the drug is safe and helps reduce fluid buildup in the heart.

This study tested two drugs—hydralazine-ISDN and metformin—in 1100 people with chronic heart failure and reduced heart function. Some participants also had diabetes or insulin resistance. The goal was to see if these drugs could lower the risk of death or hospital stays due to wo…

This study tested whether using a smartphone app and phone calls to monitor patients after a heart failure hospital stay helps doctors safely increase their medications. 66 adults with chronic heart failure and low ejection fraction were split into two groups: one received usual …

This study tested a new drug called JTT-861 in 314 adults with chronic heart failure and reduced pumping ability. Participants took either the drug or a placebo once daily for 12 weeks, alongside their usual heart medications. The goal was to see if the drug improves heart functi…

This study tested a new clinic that sees emergency room patients the next day for conditions like pneumonia, heart failure, and kidney injury. The goal was to avoid hospital stays and improve patient care. About 570 adults took part, and researchers measured how many days they we…

This early study tested a single injection of HM2002, a circular RNA, given directly into the heart muscle during bypass surgery. Only 3 people with heart failure took part. The main goal was to check safety, not to prove it works. The study is complete, but results are not yet a…

This study tested the drug spironolactone in 15 adults with chronic right-sided heart failure. The goal was to see if it is safe and can improve heart function and reduce stress on the heart. Participants took either the drug or a placebo to compare effects.

This study looked at 200 people with both heart failure and permanent atrial fibrillation. Participants received either a standard defibrillator (ICD) or one that also paces both lower heart chambers (CRT/ICD). The goal was to see if the extra pacing reduces heart size and improv…

This completed study monitored 1200 Japanese patients with chronic heart failure who were prescribed JARDIANCE® (empagliflozin) for the first time. Researchers tracked side effects, deaths, and hospitalizations over the long term to see how the drug performs in everyday use. The …

This study tested a single injection of special stem cells (Rexlemestrocel-L) into the heart for people with chronic heart failure. The goal was to see if it could reduce serious heart events like hospitalizations or death. The trial involved 565 adults and compared the stem cell…

This completed study tested a device that uses ultrasound to calm overactive nerves near the kidneys (renal denervation) in 6 people with chronic heart failure. The goal was to see if it is safe and can improve heart function by reducing sympathetic nerve activity. Because it was…

This study tested two methods of giving the diuretic furosemide (a water pill) to 50 people with sudden heart failure in the emergency department. Half received the drug as a single injection (bolus), the other half as a slow drip (continuous infusion). Researchers measured urine…

This study tested a new device called the Doraya Catheter in 25 hospitalized heart failure patients whose bodies were not responding well to standard water pills (diuretics). The goal was to see if the catheter could safely and effectively remove excess fluid. The study focused o…

This study tested whether a step-by-step plan for using diuretics (water pills) is better and safer than usual care for people hospitalized with worsening chronic heart failure. The trial involved 299 adults and compared a structured protocol using furosemide and hydrochlorothiaz…

This study tested whether providing medically tailored meals to people with heart failure could improve their diet quality. Sixty participants received heart-healthy meals delivered to their homes for 12 weeks. The main goal was to see if their diet scores improved by the end of …

This early-stage study tested a new drug called CDR132L in 28 people with stable heart failure caused by reduced blood flow to the heart. The main goal was to check if the drug is safe and how the body processes it. Participants received either the drug or a placebo, and research…

This study tested a remote monitoring system called Seerlinq HeartCore in 330 heart failure patients. Participants used a device at home to measure heart function and report symptoms. The goal was to see if this approach could reduce hospitalizations and deaths over 6 months. The…

This study tested whether a special heart scan (SPECT) can predict which people with severe chronic heart failure will improve after getting a cardiac resynchronization therapy device. The scan uses a radioactive tracer to measure nerve activity in the heart. Researchers enrolled…

This study tested a new blood test called HEARTBiT that uses 9 RNA markers to detect acute rejection in heart transplant patients. Currently, rejection is found through frequent, invasive heart biopsies. The test was developed using samples from 150 patients and will be evaluated…

This study tested whether adding leg compression to standard diuretic treatment helps people hospitalized with heart failure and severe fluid buildup. 106 adults received either diuretics alone or diuretics plus leg compression for up to 72 hours. Researchers measured changes in …

This study tests two treatments—blood flow restricted resistance exercises and low-level laser therapy—to see if they improve heart function in people with chronic heart failure. Sixty patients aged 40-60 with mild heart failure will be assigned to one of the treatments for 12 we…

This study tests whether an 8-week machine-based resistance training program can improve muscle strength and physical function in older adults (60+) who have both chronic heart failure and sarcopenia (age-related muscle loss). Researchers will measure handgrip strength and sit-to…

This trial tests whether a structured nurse-led program can improve sleep quality in adults with chronic heart failure. Participants will receive education on healthy sleep habits and cognitive-behavioral techniques, alongside their usual care. The study measures changes in sleep…

This study tests whether using a bedside ultrasound (POCUS) to check fluid levels can help doctors treat heart failure patients more effectively. 66 adults hospitalized with decompensated heart failure will be randomly assigned to get either standard care or ultrasound-guided car…

This study tests whether starting cardiopulmonary rehabilitation (exercise and breathing training) early in the hospital helps people with acute decompensated heart failure recover faster. About 40 adults who are stable enough will take part. The goal is to see if early rehab imp…

This study tested whether a home-based exercise program is practical for people with chronic heart failure who have just been hospitalized. Thirty patients were taught exercises by a physiotherapist and did them at home for 12 weeks. The goal was to see how many completed the pro…

This study tested whether adding empagliflozin (a diabetes drug) to standard diuretics helps hospitalized heart failure patients with moderate to advanced kidney disease urinate more fluid. 25 participants were given the combination, and researchers measured urine output. The goa…

This study tested whether an extended-release version of the diuretic torsemide works better than the standard immediate-release form for reducing overactive bladder symptoms in people with chronic heart failure. Twenty-four participants took each version for four weeks, tracking…

This study tested a 12-week exercise program designed for people with both congestive heart failure and knee osteoarthritis. 94 adults took part, with half doing low-impact aerobic and strength exercises and the other half receiving standard care. The goal was to see if the tailo…

This study tested whether a very high dose of the diuretic bumetanide can remove more fluid than standard doses of furosemide in people hospitalized with worsening heart failure. Twenty patients received either the ultra-high dose or the usual dose over 24 hours. The goal was to …

This study looked at whether doing resistance or aerobic exercise first during a rehab session affects heart function in men with chronic heart failure. Sixty men aged 55-65 with reduced heart pumping ability took part. Researchers measured heart function and quality of life to s…

This study looked at whether adding manual lymphatic drainage (a gentle massage technique) to early in-hospital cardiac rehabilitation helps people with acute decompensated heart failure. The goal was to reduce leg swelling and improve physical function. Forty stable hospitalized…

This early study tested a new drug called HRS-9057 in 25 adults with chronic heart failure who still had fluid buildup despite standard diuretics. The drug was given as an injection and compared to tolvaptan pills. The main goal was to check safety and how well the drug removes e…

This study tested whether acupuncture can improve heart function and quality of life in people with chronic heart failure. Fourteen patients received 10 acupuncture sessions over 5 weeks, and each person also served as their own control with a no-treatment period. Researchers mea…

This study tested whether a digital app called KardioPAC could help people in cardiac rehab stay more active and feel better. 43 heart patients used the app alongside standard rehab, or just standard rehab alone. The goal was to see if the app improved exercise habits, blood pres…

This study tested an experimental drug called OPC-131461 in 157 people with congestive heart failure who still had fluid buildup despite taking standard water pills. Participants received different doses of the drug or a placebo daily for 14 days. The main goal was to see if the …

This study tested a device called preCARDIA that temporarily blocks a large vein in the chest to help patients with sudden, severe heart failure. The goal was to see if it is safe and can help remove excess fluid when standard treatments are not working. The study included 60 adu…

This study looks at whether acute stress can cause sudden worsening of congestive heart failure. Researchers will monitor 112 heart failure patients who have an implanted device that measures pressure in the lung artery. They will compare pressure readings during stressful and ca…

This study investigates whether people with acute decompensated heart failure are taking their prescribed medications as directed. Researchers will test urine samples from 100 patients at the emergency department to directly measure drug levels, and use questionnaires to explore …

This study tested a clinical decision support tool that helps doctors identify social needs—like food, housing, or transportation—in African American patients with chronic diseases such as diabetes or heart failure. The tool uses a social risk score to flag patients who may need …

This study uses healthcare claims data from nearly 24,000 people to see if it can reproduce the results of the EMPEROR-Reduced trial, which tested the diabetes drug empagliflozin against sitagliptin in heart failure patients. The goal is not to test a new treatment, but to learn …

This study uses healthcare claims data from nearly 40,000 people to see if the results of a major clinical trial (EMPEROR-Preserved) can be reproduced in a real-world setting. Researchers are comparing two diabetes drugs, empagliflozin and sitagliptin, in patients with heart fail…

This study tested whether showing older hospitalized patients their own activity levels on a bedside screen could encourage them to move more. 130 adults aged 60+ with conditions like COPD, heart failure, or Parkinson's wore a small sensor and saw real-time feedback on time spent…

This study looked at a new way of managing chronic heart failure using nurse-led consultations. Researchers reviewed the records of 138 patients to understand how these consultations helped with adjusting medications and monitoring health. The goal was to see if this approach can…

This completed study looked at 260 patients with ischemic cardiomyopathy (a weak heart due to blocked arteries) who had heart surgery. The goal was to develop a personalized approach to choose the best type of surgery and predict risks and outcomes. Researchers used imaging, bloo…

This study tested a skin sensor that measures carbon dioxide (CO2) levels continuously during exercise, comparing it to standard blood tests. Researchers included 140 healthy volunteers and people with lung or heart conditions. The goal was to see if the sensor could accurately t…

This completed study looked at 26,000 adults with chronic heart failure in France who used a web app for remote monitoring. Researchers compared those who were digitally literate with those who were not, tracking hospitalizations and death rates. The goal was to understand whethe…

This study observed 49 adults hospitalized with acute heart failure to learn how fluid congestion behaves during treatment. Researchers tracked clinical signs, lab tests, and ultrasound measures, then followed patients for a year to see who was readmitted or died. The goal is to …

This study looked at how common vitamin D deficiency is in people with chronic heart failure and whether giving vitamin D supplements improves their health. 91 adults with heart failure were divided into groups based on their vitamin D levels. Those with severe deficiency were ra…

This study analyzed data from over 16,500 adults with chronic heart failure who were part of a remote monitoring program in France. Researchers looked at how having diabetes, other health conditions, and short-term weight changes were linked to survival. The goal was to better un…

This completed study looked at whether clinical decision support systems (CDSS) built into electronic health records help doctors better follow guidelines for chronic heart failure. Researchers analyzed data from over 66,000 patients in Russia, checking if the system increased us…

This study used blood and urine samples from 236 Japanese patients with chronic heart failure to see how biomarkers like BNP change during treatment with sacubitril valsartan or enalapril. Researchers looked for links between biomarker changes and improvements in heart failure sy…

This study tested a wearable heart monitoring patch in people recovering from a severe heart failure episode. The goal was to see if the patch could collect useful health data at home, making future drug research easier. About 54 adults wore the patch for a few days after leaving…

This study tested a program called ED GOAL that helps older adults with serious illnesses like heart failure or cancer discuss their end-of-life wishes with doctors and family, starting in the emergency department. Researchers enrolled 141 patients and measured whether the progra…

This small pilot study explored whether advanced heart imaging can detect hidden strokes in people who have never had atrial fibrillation but are at high risk due to conditions like diabetes or heart failure. Researchers used brain MRIs to find silent, symptom-free strokes and li…

This study involved 184 adults hospitalized for worsening heart failure. Researchers tracked which heart failure medications were started or adjusted during the hospital stay. The goal was to see if starting these treatments in the hospital, under close monitoring, could lead to …

This study tested a Turkish version of the Respiratory Distress Observation Scale (RDOS) in 100 adult palliative care patients who cannot describe their breathing trouble. The scale uses eight physical signs like heart rate and restlessness to rate distress. The goal was to see i…

This study looked at whether a special planning tool, called a POST form, helps older adults (65+) get the medical care they prefer at the end of life. Researchers worked with 389 people, including those with dementia, to see if their treatment matched their wishes. The goal was …

This study tested a clinical decision support tool called PREVENT to help nurses prioritize which patients need homecare most urgently after leaving the hospital. Researchers studied nearly 2,000 adults with conditions like diabetes, heart failure, and lung disease to see if the …

This study analyzed data from nearly 5,000 Japanese patients with chronic heart failure who started taking vericiguat as part of their regular care. Researchers tracked outcomes like hospital stays and deaths over one year to see how the drug performs in everyday practice. The go…

This study looked at how people with chronic heart failure or COPD process protein from meals. Researchers measured muscle building, body composition, and gut function in 90 adults aged 45 and older. The goal was to understand why muscle loss happens and how to design better diet…

This study analyzed electronic medical records of nearly 920,000 Canadian adults to see how the COVID-19 pandemic affected primary care for chronic conditions like diabetes, heart failure, and depression. Researchers compared care before and during the pandemic, looking at visits…

This early-phase study tested whether giving chloride supplements (lysine chloride) to people with stable heart failure could affect their body's fluid balance. Twenty participants took either the supplement or a placebo three times daily for five days. The goal was to understand…

This study tracked 30 adults with advanced heart failure who received a CardioMEMS implant, a wireless sensor placed in the lung artery to monitor pressure. Patients sent data from home, and doctors used it to guide care. The goal was to see if this approach reduces hospital stay…

This completed study enrolled 164 adults with chronic heart failure, some also with permanent atrial fibrillation. Researchers measured blood markers of inflammation and certain microRNAs (genetic molecules) and used echocardiograms to look at heart structure. The goal was to und…